Skip to main content
Fig. 5 | BMC Gastroenterology

Fig. 5

From: Serum O-glycosylated hepatitis B surface antigen levels in patients with chronic hepatitis B during nucleos(t)ide analog therapy

Fig. 5

Correlations between O-glycosylated HBsAg levels and HBsAg or HBcrAg levels after 48 weeks of NA therapy, stratified by HBV DNA levels at 48 weeks. Data were analyzed using Spearman’s rank correlation coefficient. Light gray circles represent HBeAg-negative patients, dark gray circles represent HBeAg-positive patients. HBcrAg hepatitis B core-related antigen, HBeAg hepatitis B e antigen, HBsAg hepatitis B surface antigen, NA nucleos(t)ide analog

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us